About
Overview
Leadership
Area of Focus
Congestion in Heart Failure
Outpatient Parenteral Antimicrobial Treatment (OPAT)
Research and Development
FUROSCIX
®
(furosemide injection) for subcutaneous administration
scCeftriaxone
Clinical Development & Medical Affairs
Investor Relations
Investor Overview
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Corporate Governance
Governance Highlights
Committee Composition
Financial Information
Sec Filings
News & Events
News Releases
Event Calendar
Presentations
Investor Resources
Investor FAQ
Information Request
E-mail Alerts
Ir Contacts
Media Resources
Careers
Contact Us
Legal
Privacy Policy
Terms of Use
scPharmaceuticals
Areas of Focus
Research & Development
Careers
Recent News
September 10, 2021
scPharmaceuticals Inc. Presents Late-breaking FREEDOM-HF Study Data at the Heart Failure Society of America Annual Scientific Meeting 2021
Read More
September 01, 2021
scPharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
Read More
August 11, 2021
scPharmaceuticals Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update
Read More
July 13, 2021
scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study
Read More
All News
